Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

C4 Therapeutics (CCCC) Debt Ratio (2020 - 2023)

C4 Therapeutics' quarterly Debt Ratio came in at 0.03 in Q2 2023, up 22.03% year-on-year from 0.02 in Q2 2022, and little changed quarter-over-quarter from 0.03 in Q1 2023.

C4 Therapeutics has reported Debt Ratio for 4 years, with the latest figure at 0.03 in Q2 2023.

  • For the quarter ending Q2 2023, Debt Ratio rose 22.03% year-over-year to 0.03; the trailing twelve-month figure through Jun 2023 stood at 0.03 (up 22.03% YoY), and the FY2022 full-year result was 0.03, up 25.42% from the prior year.
  • Debt Ratio for Q2 2023 stood at 0.03, roughly flat from 0.03 in the prior quarter.
  • The five-year high for Debt Ratio was 0.04 in Q3 2020, with the low at 0.02 in Q2 2021.
  • Average Debt Ratio over 4 years is 0.03, with a median of 0.02 recorded in 2020.
  • Year-over-year, Debt Ratio slumped 51.64% in 2021 and climbed 29.73% in 2023.
  • Tracing CCCC's Debt Ratio over 4 years: stood at 0.03 in 2020, then decreased by 15.42% to 0.02 in 2021, then grew by 25.42% to 0.03 in 2022, then gained by 3.41% to 0.03 in 2023.
  • The last three Debt Ratio figures came in at 0.03 (Q2 2023), 0.03 (Q1 2023), and 0.03 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 C4 Therapeutics 561.03 Mn 325.36 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 0.03
Mar 31, 2023 0.03
Dec 31, 2022 0.03
Sep 30, 2022 0.02
Jun 30, 2022 0.02
Mar 31, 2022 0.02
Dec 31, 2021 0.02
Sep 30, 2021 0.02
Jun 30, 2021 0.02
Mar 31, 2021 0.03
Dec 31, 2020 0.03
Sep 30, 2020 0.04